The Effect of Microbiome-Modulating Agents (MMAs) on Type 1 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Nutrients · 29.05.2024 · 16 (11) · 1675
DOI: 10.3390/nu16111675 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Nutrients, online erschienen am 29.05.2024. Verfasst von Ying Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Xiangya School of Public Health, Central South University, Changsha 410128, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Gastrointestinal Microbiome, Randomized Controlled Trials as Topic, Glycated Hemoglobin. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Gut microbiome-modulating agents (MMAs), including probiotics, prebiotics, postbiotics, and synbiotics, are shown to ameliorate type 1 diabetes (T1D) by restoring the microbiome from dysbiosis. The objective of this systematic review and meta-analysis was to assess the impact of MMAs on hemoglobin A1c (HbA1c) and biomarkers associated with (T1D). A comprehensive search was conducted in PubMed, Web of Science, Embase, Cochrane Library, National Knowledge Infrastructure, WeiPu, and WanFang Data up to 30 November 2023. Ten randomized controlled trials (n = 630) were included, with study quality evaluated using the Cochrane risk-of-bias tool. Random-effect models with standardized mean differences (SMDs) were utilized. MMA supplementation was associated with improvements in HbA1c (SMD = −0.52, 95% CI [−0.83, −0.20]), daily insulin usage (SMD = −0.41, 95% confidence interval (CI) [−0.76, −0.07]), and fasting C-peptide (SMD = 0.99, 95% CI [0.17, 1.81]) but had no effects on FBG, CRP, TNF-α, IL-10, LDL, HDL, and the Shannon index. Subgroup analysis of HbA1c indicated that a long-term intervention (>3 months) might exert a more substantial effect. These findings suggest an association between MMAs and glycemic control in T1D. Further large-scale clinical trials are necessary to confirm these findings with investigations on inflammation and gut microbiota composition while adjusting confounding factors such as diet, physical activity, and the dose and form of MMA intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xiangya School of Public Health, Central South University, Changsha 410128, China.
- Department of Chemistry, University of Washington, Seattle, WA 98195, USA.
- School of Psychology, South China Normal University, Guangzhou 510631, China.
ORCID-Profile: Ying Zhang, Jun Li, William Munthali, Lina Yang
Zitieren
APA
Zhang, Y., Huang, A., Li, J., Munthali, W., Cao, S., Putri, U. M. P., & Yang, L. (2024). The Effect of Microbiome-Modulating Agents (MMAs) on Type 1 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients, 16(11), 1675. https://doi.org/10.3390/nu16111675
Vancouver
Zhang Y, Huang A, Li J, Munthali W, Cao S, Putri UMP, et al. The Effect of Microbiome-Modulating Agents (MMAs) on Type 1 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2024;16(11):1675. doi:10.3390/nu16111675
BibTeX
@article{Zhang2024,
author = {Zhang, Ying and Huang, Aiying and Li, Jun and Munthali, William and Cao, Saiying and Putri, Ulfah Mahardika Pramono and Yang, Lina},
title = {The Effect of Microbiome-Modulating Agents (MMAs) on Type 1 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials},
journal = {Nutrients},
year = {2024},
volume = {16},
number = {11},
pages = {1675},
doi = {10.3390/nu16111675}
}
EUVIMED